InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Burgess Michael F., Responsable de la Recherche et Développement. Insider active across 2 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 4 reports have been logged. The latest transaction was disclosed on 1 June 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
15,674 shares
Common Stock
SEC:0001104659-22-002741·
15,674 shares
Common Stock
SEC:0001104659-22-002741:0·
027,500 shares0
Common Stock
SEC:0001104659-21-075168·
027,500 shares0
Common Stock
SEC:0001104659-21-075168:0·
4 of 4 declarations
About Burgess Michael F.
Michael F. Burgess is the Head of Research & Development at SpringWorks Therapeutics, Inc. He leads the company's innovation efforts, which focus on developing therapeutic treatments. Burgess plays a crucial role in research strategy, contributing to the advancement of drug development projects. His expertise is vital in ensuring the success of the company's research initiatives.
